<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37064788</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2590-2555</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Current research in immunology</Title><ISOAbbreviation>Curr Res Immunol</ISOAbbreviation></Journal><ArticleTitle>Acute to post-acute COVID-19 thromboinflammation persistence: Mechanisms and potential consequences.</ArticleTitle><Pagination><StartPage>100058</StartPage><MedlinePgn>100058</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100058</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.crimmu.2023.100058</ELocationID><Abstract><AbstractText>Concerns for the long-term effects of COVID-19 infection have grown due to frequently reported persisting symptoms that can affect multiple systems for longer than 4 weeks after initial infection, a condition known as long-COVID-19 or post-acute COVID-19 syndrome (PACS). Even nonhospitalized survivors have an elevated risk for the development of thromboinflammatory-associated events, such as ischemic stroke and heart failure, pulmonary embolism and deep vein thrombosis. Recent findings point to the persistence of many mechanisms of hypercoagulability identified to be associated with disease severity and mortality in the acute phase of the disease, such as sustained inflammation and endotheliopathy, accompanied by abnormal fibrin generation and impaired fibrinolysis. Platelets seem to be central to the sustained hypercoagulable state, displaying hyperreactivity to stimuli and increased adhesive capacity. Platelets also contribute to elevated levels of thromboinflammatory mediators and pro-coagulant extracellular vesicles in individuals with ongoing PACS. Despite new advances in the understanding of mechanisms sustaining thromboinflammation in PACS, little is known about what triggers this persistence. In this graphical review, we provide a schematic representation of the known mechanisms and consequences of persisting thromboinflammation in COVID-19 survivors and summarize the hypothesized triggers maintaining this prothrombotic state.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martins-Gon&#xe7;alves</LastName><ForeName>Remy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda&#xe7;&#xe3;o Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de Imunologia e Inflama&#xe7;&#xe3;o, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hottz</LastName><ForeName>Eugenio D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunotrombose, Departamento de Bioqu&#xed;mica, Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozza</LastName><ForeName>Patricia T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Funda&#xe7;&#xe3;o Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Res Immunol</MedlineTA><NlmUniqueID>101776898</NlmUniqueID><ISSNLinking>2590-2555</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hypercoagulability</Keyword><Keyword MajorTopicYN="N">Platelet activation</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome (PACS)</Keyword><Keyword MajorTopicYN="N">Thromboinflammation</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37064788</ArticleId><ArticleId IdType="pmc">PMC10083200</ArticleId><ArticleId IdType="doi">10.1016/j.crimmu.2023.100058</ArticleId><ArticleId IdType="pii">S2590-2555(23)00004-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bannert N., Hofmann H., Block A., Hohn O. HERVs new role in cancer: from accused perpetrators to cheerful protectors. Front. Microbiol. 2018;9:178. doi: 10.3389/fmicb.2018.00178.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00178</ArticleId><ArticleId IdType="pmc">PMC5816757</ArticleId><ArticleId IdType="pubmed">29487579</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway E.M., Mackman N., Warren R.Q., Wolberg A.S., Mosnier L.O., Campbell R.A., Gralinski L.E., Rondina M.T., van de Veerdonk F.L., Hoffmeister K.M., Griffin J.H., Nugent D., Moon K., Morrissey J.H. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 2022;22:639&#x2013;649. doi: 10.1038/s41577-022-00762-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Faverio P., Luppi F., Rebora P., D'Andrea G., Stainer A., Busnelli S., Catalano M., Modafferi G., Franco G., Monzani A., Galimberti S., Scarpazza P., Oggionni E., Betti M., Oggionni T., De Giacomi F., Bini F., Bodini B.D., Parati M., Bilucaglia L., Ceruti P., Modina D., Harari S., Caminati A., Intotero M., Sergio P., Monzillo G., Leati G., Borghesi A., Zompatori M., Corso R., Valsecchi M.G., Bellani G., Foti G., Pesci A. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study. Respir. Res. 2022;23:65. doi: 10.1186/s12931-022-01994-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-01994-y</ArticleId><ArticleId IdType="pmc">PMC8934910</ArticleId><ArticleId IdType="pubmed">35313890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A.C., Soares V.C., de Azevedo-Quintanilha I.G., Dias S., da S.G., Fintelman-Rodrigues N., Sacramento C.Q., Mattos M., de Freitas C.S., Temerozo J.R., Teixeira L., Damaceno Hottz E., Barreto E.A., P&#xe3;o C.R.R., Palhinha L., Miranda M., Bou-Habib D.C., Bozza F.A., Bozza P.T., Souza T.M.L. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Dis. 2021;7:43. doi: 10.1038/s41420-021-00428-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00428-w</ArticleId><ArticleId IdType="pmc">PMC7919254</ArticleId><ArticleId IdType="pubmed">33649297</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., Cipolla M., Viant C., Barnes C.O., Bram Y., Breton G., H&#xe4;ggl&#xf6;f T., Mendoza P., Hurley A., Turroja M., Gordon K., Millard K.G., Ramos V., Schmidt F., Weisblum Y., Jha D., Tankelevich M., Martinez-Delgado G., Yee J., Patel R., Dizon J., Unson-O&#x2019;Brien C., Shimeliovich I., Robbiani D.F., Zhao Z., Gazumyan A., Schwartz R.E., Hatziioannou T., Bjorkman P.J., Mehandru S., Bieniasz P.D., Caskey M., Nussenzweig M.C. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. 2021;41 doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Guervilly C., Bonifay A., Burtey S., Sabatier F., Cauchois R., Abdili E., Arnaud L., Lano G., Pietri L., Robert T., Velier M., Papazian L., Albanese J., Kaplanski G., Dignat-George F., Lacroix R. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv. 2021;5:628&#x2013;634. doi: 10.1182/bloodadvances.2020003308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003308</ArticleId><ArticleId IdType="pmc">PMC7846479</ArticleId><ArticleId IdType="pubmed">33560376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz E.D., Azevedo-Quintanilha I.G., Palhinha L., Teixeira L., Barreto E.A., P&#xe3;o C.R.R., Righy C., Franco S., Souza T.M.L., Kurtz P., Bozza F.A., Bozza P.T. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136:1330&#x2013;1341. doi: 10.1182/blood.2020007252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007252</ArticleId><ArticleId IdType="pmc">PMC7483437</ArticleId><ArticleId IdType="pubmed">32678428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz E.D., Martins-Gon&#xe7;alves R., Palhinha L., Azevedo-Quintanilha I.G., de Campos M.M., Sacramento C.Q., Temerozo J.R., Soares V.C., Dias S.S.G., Teixeira L., Castro I.M.S., Righy C., Souza T.M.L., Kurtz P., Andrade B., Nakaya H., Monteiro R.Q., Bozza F.A., Bozza P.T. Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19. Blood Adv. 2022;6:5085&#x2013;5099. doi: 10.1182/bloodadvances.2021006680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021006680</ArticleId><ArticleId IdType="pmc">PMC9015715</ArticleId><ArticleId IdType="pubmed">35420680</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne B.K., Denorme F., Middleton E.A., Portier I., Rowley J.W., Stubben C., Petrey A.C., Tolley N.D., Guo L., Cody M., Weyrich A.S., Yost C.C., Rondina M.T., Campbell R.A. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136:1317&#x2013;1329. doi: 10.1182/blood.2020007214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Morrone M.C., Patrono C., Santoro M.G., Schiaffino S., Remuzzi G., Bussolati G., Covid-19 Commission of the Accademia Nazionale dei Lincei Long Covid: where we stand and challenges ahead. Cell Death Differ. 2022;29:1891&#x2013;1900. doi: 10.1038/s41418-022-01052-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01052-6</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R., Campos M.M., Palhinha L., Azevedo-Quintanilha I.G., Abud Mendes M., Ramos Temerozo J., Toledo-Mendes J., Rosado-de-Castro P.H., Bozza F.A., Souza Rodrigues R., Hottz E.D., Bozza P.T. Persisting platelet activation and hyperactivity in COVID-19 survivors. Circ. Res. 2022;131:944&#x2013;947. doi: 10.1161/CIRCRESAHA.122.321659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321659</ArticleId><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizurini D.M., Hottz E.D., Bozza P.T., Monteiro R.Q. Fundamentals in covid-19-associated thrombosis: molecular and cellular aspects. Front Cardiovasc Med. 2021;8 doi: 10.3389/fcvm.2021.785738.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.785738</ArticleId><ArticleId IdType="pmc">PMC8718518</ArticleId><ArticleId IdType="pubmed">34977191</ArticleId></ArticleIdList></Reference><Reference><Citation>Moraes E.C.S., Martins-Gon&#xe7;alves R., Silva L.R., Mandacaru S.C., Melo R.M., Azevedo-Quintanilha I., Perales J., Bozza F.A., Souza T.M.L., Castro-Faria-Neto H.C., Hottz E.D., Bozza P.T., Trugilho M.R.O. Proteomic profile of procoagulant extracellular vesicles reflects complement system activation and platelet hyperreactivity of patients with severe COVID-19. Front. Cell. Infect. Microbiol. 2022;12, 926352 doi: 10.3389/fcimb.2022.926352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.926352</ArticleId><ArticleId IdType="pmc">PMC9354812</ArticleId><ArticleId IdType="pubmed">35937696</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw. Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R., Bogue T., Koshy A., Bindal P., Merrill M., Aird W.C., Bauer K.A., Zwicker J.I. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136:1342&#x2013;1346. doi: 10.1182/blood.2020007938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007938</ArticleId><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S.P., Wei X., Kwong J.C., Gubbay J., Schwartz K.L., Majury A., Groome P.A. Duration of SARS-CoV-2 shedding: a population-based, Canadian study. PLoS One. 2021;16 doi: 10.1371/journal.pone.0252217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252217</ArticleId><ArticleId IdType="pmc">PMC8211234</ArticleId><ArticleId IdType="pubmed">34138906</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues R.S., Motta Ribeiro G., Barreto M.M., Zin W.A., de Toledo-Mendes J., Martins P.A.G., de Almeida S.A., Bas&#xed;lio R., Martins-Gon&#xe7;alves R., Hottz E.D., Bozza P.T., Bozza F.A., Carvalho A.R.S., Rosado-de-Castro P.H. Increased lung immune metabolic activity in COVID-19 survivors. Clin. Nucl. Med. 2022;47:1019&#x2013;1025. doi: 10.1097/RLU.0000000000004376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000004376</ArticleId><ArticleId IdType="pmc">PMC9653065</ArticleId><ArticleId IdType="pubmed">36026599</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., Girndt M., H&#xf6;ll J.I., Gekle M., Mikolajczyk R., Binder M. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3 doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.-Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., Ko S.H., Platt A.P., Burbelo P.D., Quezado M., Pittaluga S., Purcell M., Munster V.J., Belinky F., Ramos-Benitez M.J., Boritz E.A., Lach I.A., Herr D.L., Rabin J., Saharia K.K., Madathil R.J., Tabatabai A., Soherwardi S., McCurdy M.T., NIH COVID-19 Autopsy Consortium. Peterson K.E., Cohen J.I., de Wit E., Vannella K.M., Hewitt S.M., Kleiner D.E., Chertow D.S. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022:1&#x2013;6. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., Kornilov S.A., Scherler K., Pavlovitch-Bedzyk A.J., Dong S., Lausted C., Lee I., Fallen S., Dai C.L., Baloni P., Smith B., Duvvuri V.R., Anderson K.G., Li J., Yang F., Duncombe C.J., McCulloch D.J., Rostomily C., Troisch P., Zhou J., Mackay S., DeGottardi Q., May D.H., Taniguchi R., Gittelman R.M., Klinger M., Snyder T.M., Roper R., Wojciechowska G., Murray K., Edmark R., Evans S., Jones L., Zhou Y., Rowen L., Liu R., Chour W., Algren H.A., Berrington W.R., Wallick J.A., Cochran R.A., Micikas M.E., Wrin T., Petropoulos C.J., Cole H.R., Fischer T.D., Wei W., Hoon D.S.B., Price N.D., Subramanian N., Hill J.A., Hadlock J., Magis A.T., Ribas A., Lanier L.L., Boyd S.D., Bluestone J.A., Chu H., Hood L., Gottardo R., Greenberg P.D., Davis M.M., Goldman J.D., Heath J.R. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Temerozo J.R., Fintelman-Rodrigues N., Dos Santos M.C., Hottz E.D., Sacramento C.Q., de Paula Dias da Silva A., Mandacaru S.C., Dos Santos Moraes E.C., Trugilho M.R.O., Gesto J.S.M., Ferreira M.A., Saraiva F.B., Palhinha L., Martins-Gon&#xe7;alves R., Azevedo-Quintanilha I.G., Abrantes J.L., Righy C., Kurtz P., Jiang H., Tan H., Morel C., Bou-Habib D.C., Bozza F.A., Bozza P.T., Souza T.M.L. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome. 2022;10:65. doi: 10.1186/s40168-022-01260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01260-9</ArticleId><ArticleId IdType="pmc">PMC9024070</ArticleId><ArticleId IdType="pubmed">35459226</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin&#x2010;Loeches I., Bannan C., Nadarajan P., Bergin C., O'Farrelly C., Conlon N., Bourke N.M., Ward S.E., Byrne M., Ryan K., O'Connell N., O'Sullivan J.M., Ni Cheallaigh C., O'Donnell J.S. Prolonged elevation of D&#x2010;dimer levels in convalescent COVID&#x2010;19 patients is independent of the acute phase response. J. Thromb. Haemostasis. 2021;19:1064&#x2013;1070. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Naidoo C.A., Usher T.J., Kruger A., Venter C., Laubscher G.J., Khan M.A., Kell D.B., Pretorius E. Increased levels of inflammatory molecules in blood of Long COVID patients point to thrombotic endotheliitis. 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.13.22281055</ArticleId><ArticleId IdType="pubmed">37207671</ArticleId></ArticleIdList></Reference><Reference><Citation>Veras F.P., Pontelli M.C., Silva C.M., Toller-Kawahisa J.E., de Lima M., Nascimento D.C., Schneider A.H., Caetit&#xe9; D., Tavares L.A., Paiva I.M., Rosales R., Col&#xf3;n D., Martins R., Castro I.A., Almeida G.M., Lopes M.I.F., Benatti M.N., Bonjorno L.P., Giannini M.C., Luppino-Assad R., Almeida S.L., Vilar F., Santana R., Bollela V.R., Auxiliadora-Martins M., Borges M., Miranda C.H., Pazin-Filho A., da Silva L.L.P., Cunha L.D., Zamboni D.S., Dal-Pizzol F., Leiria L.O., Siyuan L., Batah S., Fabro A., Mauad T., Dolhnikoff M., Duarte-Neto A., Saldiva P., Cunha T.M., Alves-Filho J.C., Arruda E., Louzada-Junior P., Oliveira R.D., Cunha F.Q. SARS-CoV-2&#x2013;triggered neutrophil extracellular traps mediate COVID-19 pathologySARS-CoV-2 directly triggers ACE-dependent NETs. J. Exp. Med. 2020;217 doi: 10.1084/jem.20201129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201129</ArticleId><ArticleId IdType="pmc">PMC7488868</ArticleId><ArticleId IdType="pubmed">32926098</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F., Pignatelli P., Vestri A.R., Spagnoli A., Cipollone F., Ceccarelli G., Oliva A., Amitrano M., Pirro M., Taliani G., Cangemi R., Lichtner M., Pugliese F., Falcone M., D'Ardes D., Venditti M., Mastroianni C.M., Loffredo L., ADA GROUP . Thromb Haemost; 2022. The ADA (Age-D-Dimer-Albumin) Score to Predict Thrombosis in SARS-CoV-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1788-7592</ArticleId><ArticleId IdType="pubmed">35253143</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Pendurthi U.R., Yi G., Rao L.V.M. SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase. Blood. 2021;138:344&#x2013;349. doi: 10.1182/blood.2021010685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021010685</ArticleId><ArticleId IdType="pmc">PMC8172270</ArticleId><ArticleId IdType="pubmed">34075401</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022:1&#x2013;8. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>